Lepivil 25mg Tablet contains Levosulpiride, a selective dopamine D2 receptor antagonist used primarily for the treatment of gastrointestinal disorders and certain psychiatric conditions. Levosulpiride exhibits prokinetic and antiemetic properties by enhancing gastric motility and modulating dopaminergic pathways in the central nervous system. It is commonly prescribed for functional dyspepsia, gastroesophageal reflux disease (GERD), and delayed gastric emptying, providing symptomatic relief from nausea, vomiting, bloating, and abdominal discomfort. Additionally, Levosulpiride has been utilized in the management of psychiatric disorders such as depression and schizophrenia due to its antidepressant and antipsychotic effects. The recommended dosage of Lepivil 25mg should be determined by a healthcare professional based on the patient’s clinical condition. It is generally well tolerated; however, potential side effects may include drowsiness, dizziness, dry mouth, and extrapyramidal symptoms in rare cases. Caution is advised in patients with a history of hypersensitivity to sulpiride derivatives, and it should be used cautiously in individuals with renal or hepatic impairment. Lepivil 25mg Tablet should not be combined with other dopamine antagonists without medical supervision. Regular monitoring and adherence to prescribed dosage are essential to ensure therapeutic efficacy and minimize adverse effects.